Citadel Advisors’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $179K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.16M | Buy |
|
|||||
|
2024
Q3 | $1.47M | Buy |
|
|||||
|
2024
Q2 | $222K | Sell |
|
|||||
|
2024
Q1 | $1.03M | Sell |
|
|||||
|
2023
Q4 | $9.6M | Sell |
|
|||||
|
2023
Q3 | $8.94M | Buy |
|
|||||
|
2023
Q2 | $7.62M | Buy |
|
|||||
|
2023
Q1 | $1.01M | Buy |
|
|||||
|
2022
Q4 | $686K | Sell |
|
|||||
|
2022
Q3 | $2.02M | Sell |
|
|||||
|
2022
Q2 | $1.71M | Buy |
|
|||||
|
2022
Q1 | $928K | Buy |
|
|||||
|
2021
Q4 | $230K | Sell |
|
|||||
|
2021
Q3 | $710K | Sell |
|
|||||
|
2021
Q2 | $1.82M | Buy |
|
|||||
|
2021
Q1 | $1.17M | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $715K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $118K | Sell |
|
|||||
|
2019
Q2 | $467K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $18K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $28K | Buy |
|